Quality of life in patients affected by medication-related osteonecrosis of the jaws: A systematic review

Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Aug;132(2):182-189. doi: 10.1016/j.oooo.2021.03.006. Epub 2021 Mar 14.

Abstract

Objective: The aim of this systematic review was to describe the quality of life and oral health-related quality of life of patients affected by medication-related osteonecrosis of the jaw.

Study design: The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A combination of keywords and MeSH terms was used in PubMed, Scopus, Cochrane Library, Web of Science, and EBSCO up to December 13, 2020.

Results: A total of 1066 results were obtained after duplicate exclusion and 11 articles were included in the final qualitative analysis. Most of the articles described the quality of life in patients with osteonecrosis of the jaw secondary to cancer treatment. The main drugs associated with the disease were bisphosphonates. Surgical treatment of the osteonecrosis improves the quality of life of these patients.

Conclusions: The present systematic review suggested the negative influence of osteonecrosis of the jaw on the quality of life and oral health-related quality of life among oncologic and osteoporotic patients. The use of quality of life questionnaires in daily practice could be an important tool to better diagnose and manage patients affected by osteonecrosis of the jaws who have received or are receiving drugs associated with this complication.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw*
  • Bone Density Conservation Agents* / adverse effects
  • Diphosphonates
  • Humans
  • Jaw
  • Osteonecrosis* / chemically induced
  • Quality of Life

Substances

  • Bone Density Conservation Agents
  • Diphosphonates